Nicotrol NS Related Published Studies
Well-designed clinical trials related to Nicotrol NS (Nicotine Nasal)
Nicotine nasal spray as an adjuvant analgesic for third molar surgery. [2011.05]
Direction and magnitude of nicotine effects on the fMRI BOLD response are related to nicotine effects on behavioral performance. [2011.05]
Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial. [2011.04]
Treating heavy smokers in primary care with the nicotine nasal spray: randomized
placebo-controlled trial. [2011]
Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. [2009.09]
Use of nicotine substitute prescribed at hourly plus ab libitum intake or ad libitum for heavy smokers willing to quit: a randomized controlled trial. [2009.06.02]
Positive effects of nicotine on cognition: the deployment of attention for prospective memory. [2009.01]
A randomized trial of nicotine nasal spray in adolescent smokers. [2008.09]
Transdermal nicotine patch for postoperative pain management: a pilot dose-ranging study. [2008.09]
Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. [2008.02]
Gender differences in affective response to acute nicotine administration and deprivation. [2007.03]
Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency? [2007.03]
Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. [2006.07]
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. [2006.06]
Effects of nicotine nasal spray on cognitive function in schizophrenia. [2006.03]
The influence of mecamylamine on trigeminal and olfactory chemoreception of nicotine. [2006.02]
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials. [2006.01]
The discriminative stimulus, subjective, cardiovascular, and reinforcing effects of nicotine as a function of light physical activity. [2005.10]
Effects of different nicotine replacement therapies on postcessation psychological responses. [2005.01]
Instructions about nicotine dose influence acute responses to nasal spray. [2004.12]
Intranasal nicotine for postoperative pain treatment. [2004.12]
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. [2004.03.16]
Comparative testing of 5 nicotine systems: initial use and preferences. [2004.01]
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. [2004]
The consistency of acute responses to nicotine in humans. [2003.12]
Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. [2003.11.24]
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. [2003.04]
The effects of nicotine on specific eye tracking measures in schizophrenia. [2002.10.01]
Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. [2002.09]
Contribution of nicotine to acute endothelial dysfunction in long-term smokers. [2002.01.16]
Individual differences in preferences for and responses to four nicotine replacement products. [2001.01.01]
Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. [2000.11]
Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. [2000]
Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. [1999.09.27]
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. [1999.07]
Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man. [1999.03]
Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. [1999.01.30]
Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. [1998.11]
A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. [1997.07]
No acute effects of smoking and nicotine nasal spray on lipolysis measured by subcutaneous microdialysis. [1997.06]
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. [1997.03]
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? [1997.01]
Recycling of hard-core smokers with nicotine nasal spray. [1996.08]
Influence of training dose on nicotine discrimination in humans. [1996.07]
Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. [1996.03]
Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. [1995.12]
Subjective and cardiovascular responses to nicotine combined with alcohol in male and female smokers. [1995.05]
Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant. [1995]
Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. [1994.11.28]
Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers. [1994.09]
Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. [1994.01.15]
Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity. [1994.01]
Effects of nicotine on the human nasal mucosa. [1993.06]
Randomised controlled trial of nasal nicotine spray in smoking cessation. [1992.08.08]
Nasal nicotine spray: a rapid nicotine delivery system. [1992]
Well-designed clinical trials possibly related to Nicotrol NS (Nicotine Nasal)
Prospective memory or prospective attention: physiological and pharmacological support for an attentional model. [2008.05]
The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial. [2006.03]
[Controlled randomized trials of pharmaceutic aids for smoking cessation. Results and perspectives] [1994.07]
Other research related to Nicotrol NS (Nicotine Nasal)
Nicotine replacement therapy for smoking cessation. [2012]
Non-suicidal self-injury by intravenous application of nicotine in a patient with borderline personality disorder resulting in substance dependence. [2011.06]
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. [2011.05.01]
SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. [2011.03.01]
Nicotine nasal spray as an adjuvant analgesic for third molar surgery. [2011]
Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats. [2010.08]
The effects of response operandum and prior food training on intravenous nicotine self-administration in rats. [2010.07]
Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways. [2010.01.29]
Nicotine dependence and smoking cessation. [2009.11]
Substance use, trait measures, and subjective response to nicotine in never-smokers stratified on parental smoking history and sex. [2009.09]
Lack of reinforcement enhancing effects of nicotine in non-dependent smokers. [2009.09]
[New modes of tobacco and nicotine use] [2009.07.01]
Mood, nicotine, and dose expectancy effects on acute responses to nicotine spray. [2009.05]
Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. [2009.01.01]
[Smoking cessation with nicotine replacement therapy (NRT) - a scientific update] [2009]
Discriminative stimulus effects of nicotine in humans. [2009]
The motivation to obtain nicotine-conditioned reinforcers depends on nicotine dose. [2008.12]
Nicotine differentially inhibits the acoustic startle reflex in African American and Caucasian American smokers. [2008.12]
Initial nicotine sensitivity in humans as a function of impulsivity. [2008.11]
Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch. [2008.10.01]
Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A). [2008.10]
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. [2008.09]
Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. [2008.08]
Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. [2008.08]
Nicotine replacement therapy for smoking cessation. [2008.01.23]
Nicotine effects on retrieval-induced forgetting are not attributable to changes in arousal. [2008.01]
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs] [2008]
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline? [2007.12]
The effect of nicotine on perceptual, ocular motor, postural, and vegetative functions at rest and in motion. [2007.12]
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. [2007.11]
Nicotine Effect on Prepulse Inhibition and Prepulse Facilitation in Schizophrenia Patients. [2007.10.24]
Facial EMG as an index of affective response to nicotine. [2007.08]
Dose-Related Enhancement of Mood and Cognition in Smokers Administered Nicotine Nasal Spray. [2007.04.18]
Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. [2007.03]
'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration. [2007.02]
mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats. [2007.02]
Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men. [2007.01]
Pharmacogenetics and smoking cessation with nicotine replacement therapy. [2007]
Acute effect of cigarette smoke and nicotine on airway blood flow and airflow in healthy smokers. [2006.11]
Absorption of nicotine induces oxidative stress among bidi workers. [2006.10]
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. [2006.05]
[Does nicotine add to the carcinogenic strain of tobacco smoke?] [2006.05]
Using nicotine replacement therapy in treating nicotine addiction in adolescents. [2001.10]
|
